Abbott Laboratories South Africa (Pty) Ltd Submission Date: 17 February 2023 Type: Type II INFLUVAC SUBUNIT Approval Date: 8 March 2023 Category: (Q) B.I.a.5.a Multicomponent, 15 µg injection Implementation: 8 March 2023 Code: eSubmission QSV Country Code: ZA (South Africa) Registration No.:T/30.1/581序列号:0006